Heidelberg Pharma Price To Book vs. Revenue
| HPHA Stock | EUR 2.42 0.00 0.00% |
For Heidelberg Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Heidelberg Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Heidelberg Pharma AG utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Heidelberg Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Heidelberg Pharma AG over time as well as its relative position and ranking within its peers.
Heidelberg |
Heidelberg Pharma Revenue vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Heidelberg Pharma's current stock value. Our valuation model uses many indicators to compare Heidelberg Pharma value to that of its competitors to determine the firm's financial worth. Heidelberg Pharma AG is one of the top stocks in price to book category among its peers. It is rated below average in revenue category among its peers totaling about 68,734 of Revenue per Price To Book. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Heidelberg Pharma's earnings, one of the primary drivers of an investment's value.Heidelberg Revenue vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Heidelberg Pharma |
| = | 25.46 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Heidelberg Pharma |
| = | 1.75 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Heidelberg Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Heidelberg Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Heidelberg Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Heidelberg Pharma's important profitability drivers and their relationship over time.
Use Heidelberg Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Heidelberg Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heidelberg Pharma will appreciate offsetting losses from the drop in the long position's value.Heidelberg Pharma Pair Trading
Heidelberg Pharma AG Pair Trading Analysis
The ability to find closely correlated positions to Heidelberg Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Heidelberg Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Heidelberg Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Heidelberg Pharma AG to buy it.
The correlation of Heidelberg Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Heidelberg Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Heidelberg Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Heidelberg Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Heidelberg Pharma position
In addition to having Heidelberg Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Outsourcing Thematic Idea Now
Outsourcing
Companies involved in providing outsourcing and staffing services to business across different domains. The Outsourcing theme has 8 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Outsourcing Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Heidelberg Stock Analysis
When running Heidelberg Pharma's price analysis, check to measure Heidelberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heidelberg Pharma is operating at the current time. Most of Heidelberg Pharma's value examination focuses on studying past and present price action to predict the probability of Heidelberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heidelberg Pharma's price. Additionally, you may evaluate how the addition of Heidelberg Pharma to your portfolios can decrease your overall portfolio volatility.